The study of oxidative stress biomarkers in patients undergoing ant tuberculosis treatment provides valuable insights into the complex biological changes occurring during the therapeutic process. Oxidative stress refers to the imbalance between the productions of reactive oxygen species and the body’s ability to detoxify these harmful molecules or repair the damage they cause. In the context of tuberculosis, oxidative stress has been implicated in the disease's pathogenesis, affecting both the infection itself and the subsequent healing process during treatment. This pilot study aimed to investigate the variations in serum oxidative stress biomarkers in patients receiving first-line antituberculosis therapy, contributing to a deeper understanding of how such therapies influence the body’s oxidative status. Tuberculosis remains one of the leading infectious diseases globally, primarily affecting the lungs but capable of impacting other organs.
HTML PDFShare this article
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report
